Express Healthcare
Home  »  COVID-19 Updates  »  Zydus begins human trials for potential COVID-19 vaccine

Zydus begins human trials for potential COVID-19 vaccine

0 42
Read Article

Zydus will enrol over 1,000 subjects across multiple clinical study sites in India

Zydus has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said in Bengaluru.

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Leave A Reply

Your email address will not be published.